Literature DB >> 25254156

Cognition in schizophrenia: Past, present, and future.

Michael F Green1, Philip D Harvey2.   

Abstract

Schizophrenia Research: Cognition will serve an important function - a place where interests converge and investigators can learn about the recent developments in this area. This new journal will provide rapid dissemination of information to people who will make good use of it. In this initial article, we comment globally on the study of cognition in schizophrenia: how we got here, where we are, and where we are going. The goal of this first article is to place the study of cognition in schizophrenia within a historical and scientific context. In a field as richly textured as ours it is impossible to hit all the important areas, and we hope the reader will forgive our omissions. Phrased in cognitive terms, our limited presentation of the past is a matter of selective memory, the present is a matter of selective attention, and the future is a matter of selective prospection. This broad introduction emphasizes that cognition in schizophrenia provides clues to pathophysiology, treatment, and outcome. In fact, the study of cognitive impairment in schizophrenia has become wholly intertwined with the study of schizophrenia itself.

Entities:  

Keywords:  Cognition; History; Schizophrenia

Year:  2014        PMID: 25254156      PMCID: PMC4171037          DOI: 10.1016/j.scog.2014.02.001

Source DB:  PubMed          Journal:  Schizophr Res Cogn        ISSN: 2215-0013


  87 in total

1.  Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies.

Authors:  Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch
Journal:  Schizophr Bull       Date:  2010-12-01       Impact factor: 9.306

Review 2.  Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5.

Authors:  Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; Rajiv Tandon; Ming Tsuang; Jim Van Os; William Carpenter
Journal:  Schizophr Res       Date:  2013-05-22       Impact factor: 4.939

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

5.  Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium.

Authors:  James M Gold; Deanna M Barch; Cameron S Carter; Steven Dakin; Steven J Luck; Angus W MacDonald; J Daniel Ragland; Charan Ranganath; Ilona Kovacs; Steven M Silverstein; Milton Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

6.  Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging.

Authors:  S Raz; N Raz
Journal:  Psychol Bull       Date:  1990-07       Impact factor: 17.737

7.  Factor structure of neurocognition and functional capacity in schizophrenia: a multidimensional examination of temporal stability.

Authors:  Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson
Journal:  J Int Neuropsychol Soc       Date:  2013-02-21       Impact factor: 2.892

Review 8.  Cognitive remediation in schizophrenia: is it time yet?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1993-02       Impact factor: 18.112

9.  Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Richard S E Keefe; John A Sweeney; Hongbin Gu; Robert M Hamer; Diana O Perkins; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

Review 10.  Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review.

Authors:  Birgit Guse; Peter Falkai; Thomas Wobrock
Journal:  J Neural Transm (Vienna)       Date:  2009-10-27       Impact factor: 3.575

View more
  59 in total

Review 1.  Raising attention to attention deficit hyperactivity disorder in schizophrenia.

Authors:  Stefano Pallanti; Luana Salerno
Journal:  World J Psychiatry       Date:  2015-03-22

Review 2.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

3.  Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine.

Authors:  Indrani Poddar; Patrick M Callahan; Caterina M Hernandez; Xiangkun Yang; Michael G Bartlett; Alvin V Terry
Journal:  Biochem Pharmacol       Date:  2017-11-24       Impact factor: 5.858

4.  Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.

Authors:  Guillaume Fond; F Berna; L Boyer; O Godin; L Brunel; M Andrianarisoa; B Aouizerate; D Capdevielle; I Chereau; J M Danion; C Dubertret; J Dubreucq; C Faget; F Gabayet; T Le Gloahec; P M Llorca; J Mallet; D Misdrahi; R Rey; R Richieri; C Passerieux; C Portalier; P Roux; A Vehier; H Yazbek; F Schürhoff; E Bulzacka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-27       Impact factor: 5.270

5.  Factors Associated with Changes in Community Ability and Recovery After Psychiatric Rehabilitation: A Retrospective Study.

Authors:  Bhing-Leet Tan; Wai-Yee Ng; Jayson Sudhasan; Thomas Chng; Irene Mok; Jimmy Lee
Journal:  Community Ment Health J       Date:  2018-02-26

6.  Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.

Authors:  Kevin M Antshel; Wanda Fremont; Seetha Ramanathan; Wendy R Kates
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

7.  Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia.

Authors:  Juan L Molina; Bradley Voytek; Michael L Thomas; Yash B Joshi; Savita G Bhakta; Jo A Talledo; Neal R Swerdlow; Gregory A Light
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-02-22

8.  New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease.

Authors:  Young-Cho Kim; Stephanie L Alberico; Eric Emmons; Nandakumar S Narayanan
Journal:  Front Biol (Beijing)       Date:  2015-05-13

Review 9.  Social cognition in schizophrenia.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

10.  [Schizophrenia and bipolar disorder : Treatment of cognitive impairments].

Authors:  P Riedel; M N Smolka; M Bauer
Journal:  Nervenarzt       Date:  2018-07       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.